All Stories
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
-
Working Together: DaVita Celebrates Joint Efforts to Advance Kidney Health Awareness and Access to Care
Kidney disease affects an estimated 35 million Americans, with 90% unaware until it’s critical. As DaVita celebrates its 25th anniversary, it remains dedicated to changing this by prioritizing…
-
The Power and Art of Possibility: Insights from DaVita’s Chief Information Officer on Health Tech Innovation
In this Q&A, Madhu Narasimhan, chief information officer at DaVita, discusses how DaVita integrates innovation with compassionate care, empowering both patients and caregivers. What do you see as…
-
Keep Moving Forward: How George Godoy Transformed His Dialysis Experience
At just 16 years old, George Godoy received life-altering news: He had been born with one kidney affected by polycystic kidney disease. When he finished high school, Godoy watched as friends and…
-
Proactive Kidney Care: A Comprehensive Approach
Chronic kidney disease (CKD) is a silent epidemic, often progressing undetected until it reaches later stages when only a kidney transplant or dialysis can sustain life. But a resilient solution…
-
Overwhelmed But Not Overcome: How One Patient Found Career Inspiration in His Own Health Journey
When Chris Harris found out his kidneys were failing, it felt like his world came crashing down. Harris was 26 years old when he started to feel incredibly sick. He was working as an assistant…